INVITRO VENOUS PROSTACYCLIN PRODUCTION, PLASMA 6-KETO-PROSTAGLANDIN-F1-ALPHA CONCENTRATIONS, AND DIABETIC-RETINOPATHY

被引：59
作者：
DAVIS, TME
BOWN, E
FINCH, DR
MITCHELL, MD
TURNER, RC
机构：
[1] JOHN RADCLIFFE HOSP, NUFFIELD DEPT SURG, OXFORD OX3 9DU, ENGLAND
[2] JOHN RADCLIFFE HOSP, NUFFIELD DEPT OBSTET & GYNAECOL, OXFORD OX3 9DU, ENGLAND
来源：
BMJ-BRITISH MEDICAL JOURNAL | 1981年 / 282卷 / 6272期
关键词：
D O I：
10.1136/bmj.282.6272.1259
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1259 / 1262
页数：4
相关论文
共 22 条
[1]  
DAVIS TME, 1980, LANCET, V1, P373
[2]  
DAVIS TME, 1979, LANCET, V2, P789
[3]  
DEBONO D, 1975, BRIT J EXP PATHOL, V56, P8
[4]  
DOLLERY CT, 1979, LANCET, V2, P1365
[5]   MORBIDITY AND MORTALITY IN DIABETICS IN FRAMINGHAM POPULATION - 16-YEAR FOLLOW-UP STUDY [J].
GARCIA, MJ ;
MCNAMARA, PM ;
GORDON, T ;
KANNELL, WB .
DIABETES, 1974, 23 (02) :105-111
[6]   EFFECT OF INSULIN-TREATMENT ON PROSTACYCLIN IN EXPERIMENTAL DIABETES [J].
HARRISON, HE ;
REECE, AH ;
JOHNSON, M .
DIABETOLOGIA, 1980, 18 (01) :65-68
[7]   DECREASED VASCULAR PROSTACYCLIN IN EXPERIMENTAL DIABETES [J].
HARRISON, HE ;
REECE, AH ;
JOHNSON, M .
LIFE SCIENCES, 1978, 23 (04) :351-356
[8]  
JARRETT RJ, 1976, LANCET, V2, P1009
[9]  
JOHNSON M, 1979, LANCET, V1, P325
[10]  
JORGENSEN KA, 1979, LANCET, V1, P1352
123